Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging

NMR in Biomedicine

Volumn 15, Issue 2, 2002, Pages 154-163

  Hayes, Carmel ^a,b   Padhani, Anwar R ^a   Leach, Martin O ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b SIEMENS AG   (Germany)

Author keywords

Breast cancer; Contrast enhanced MRI; Transfer constant; Tumour response

Indexed keywords

CHEMOTHERAPY; DIAGNOSIS; IMAGE ANALYSIS; TUMORS;

VOLUME TRANSFER;

BIOMEDICAL ENGINEERING;

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GADOLINIUM PENTETATE; METHOTREXATE; MITOXANTRONE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DISTRIBUTION; EXTRACELLULAR SPACE; EXTRAVASCULAR SPACE; FEMALE; HISTOGRAM; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTITION COEFFICIENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL PROCESSING; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SPINE;

EID: 0036194959     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.756     Document Type: Article

References (42)

1. Tumor heterogeneity
2. Physiological resistance to the treatment of solid tumors
3. Angiogenesis and blood flow in solid tumors
4. Examining the technique of angiogenesis assessment in invasive breast cancer
5. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies
6. Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy
7. Positron emission tomography using [(18)F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer
8. Pathophysiologic basis of contrast enhancement in breast tumors
9. Breast lesions: Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis
10. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI
11. Suspect breast lesions: Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features
12. Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors
13. Angiogenic response of MCF7 human breast cancer to hormonal treatment: Assessment by dynamic Gd-DTPA-enhanced MRI at high spatial resolution
14. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging
15. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations
16. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: A method for early therapy evaluation?
17. Diffusion magnetic resonance imaging: An early surrogate marker of therapeutic efficacy in brain tumors
18. Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: Initial results
19. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR Imaging 1. Fundamental concepts
20. 1-weighted MRI of a diffusable tracer: Standardized quantities and symbols
21. Response of breast carcinoma to chemotherapy-MR permeability changes using histogram analysis
22. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics
23. Improving image quality and T(1) measurements using saturation recovery turbo-FLASH with an approximate K-space normalisation filter
24. MRIW: Parametric analysis software for contrast-enhanced dynamic MR imaging in cancer
25. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue
26. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging
27. Breast disease: Dynamic spiral MR imaging
28. Changes in the findings of dynamic MRI by preoperative CAF chemotherapy for patients with breast cancer of stage II and III: Pathologic correlation
29. Locally advanced breast cancer treated with primary chemotherapy: Comparison between magnetic resonance imaging and pathologic evaluation of residual disease
30. Prediction of tumor control in patients with cervical cancer: Analysis of combined volume and dynamic enhancement pattern by MR imaging
31. Uterine cervical carcinoma: Comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival
32. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model
33. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
34. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA
35. Contrast-enhanced magnetic resonance imaging of the breast
36. MR characterization of suspicious breast lesions with a gadolinium-enhanced Turbo-FLASH subtraction technique
37. Dynamic MRI of invasive breast cancer: Assessment of three region-of-interest analysis methods
38. Observer variability in the interpretation of contrast enhanced MRI of the breast
39. Heterogeneity analysis of Gd-DTPA uptake: Improvement in breast lesion differentiation
40. Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors
41. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: Pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy
42. Effects of novel and conventional anti-cancer agents on human endothelial permeability: Influence of tumour secreted factors